van den Born J, van Kraats A A, Bakker M A, Assmann K J, van den Heuvel L P, Veerkamp J H, Berden J H
Department of Nephrology, University Hospital St. Radbound, Nijmegen, The Netherlands.
Diabetologia. 1995 Feb;38(2):161-72. doi: 10.1007/BF00400090.
In the present study we investigated whether glomerular hyperfiltration and albuminuria in streptozotocin-induced diabetic nephropathy in male Wistar-Münich rats are associated with changes in the heparan sulphate content of the glomerular basement membrane. Rats with a diabetes mellitus duration of 8 months, treated with low doses of insulin, showed a significant increase in glomerular filtration rate (p < 0.01) and effective renal plasma flow (p < 0.05), without alterations in filtration fraction or mean arterial blood pressure. Diabetic rats developed progressive albuminuria (at 7 months, diabetic rats (D): 42 +/- 13 vs control rats (C): 0.5 +/- 0.2 mg/24 h, p < 0.002) and a decrease of the selectivity index (clearance IgG/clearance albumin) of the proteinuria (at 7 months, D: 0.20 +/- 0.04 vs C: 0.39 +/- 0.17, p < 0.05), suggesting loss of glomerular basement membrane charge. Light- and electron microscopy demonstrated a moderate increase of mesangial matrix and thickening of the glomerular basement membrane in the diabetic rats. Immunohistochemically an increase of laminin, collagen III and IV staining was observed in the mesangium and in the glomerular basement membrane, without alterations in glomerular basement membrane staining of heparan sulphate proteoglycan core protein or heparan sulphate. Glomerular basement membrane heparan sulphate content, quantitated in individual glomerular extracts by a new inhibition ELISA using a specific anti-glomerular basement membrane heparan sulphate monoclonal antibody (JM403), was not altered (median (range) D: 314 (152-941) vs C: 262 (244-467) ng heparan sulphate/mg glomerulus). However, the amount of glomerular 4-hydroxyproline, as a measure for collagen content, was significantly increased (D: 1665 (712-2014) vs C: 672 (515-1208) ng/mg glomerulus, p < 0.01). Consequently, a significant decrease of the heparan sulphate/4-hydroxyproline ratio (D: 0.21 (0.14-1.16) vs C: 0.39 (0.30-0.47), p < 0.05) was found. In summary, we demonstrate that in streptozotocin-diabetic rats glomerular hyperfiltration and a progressive, selective proteinuria are associated with a relative decrease of glomerular basement membrane heparan sulphate. Functionally, a diminished heparan sulphate-associated charge density within the glomerular basement membrane might explain the selective proteinuria in the diabetic rats.
在本研究中,我们调查了链脲佐菌素诱导的雄性Wistar - Munich大鼠糖尿病肾病中的肾小球高滤过和蛋白尿是否与肾小球基底膜硫酸乙酰肝素含量的变化有关。糖尿病病程8个月且接受低剂量胰岛素治疗的大鼠,其肾小球滤过率显著增加(p < 0.01),有效肾血浆流量增加(p < 0.05),而滤过分数或平均动脉血压无变化。糖尿病大鼠出现进行性蛋白尿(7个月时,糖尿病大鼠(D):42±13 vs对照大鼠(C):0.5±0.2 mg/24 h,p < 0.002),蛋白尿的选择性指数(清除率IgG/清除率白蛋白)降低(7个月时,D:0.20±0.04 vs C:0.39±0.17,p < 0.05),提示肾小球基底膜电荷丧失。光镜和电镜显示糖尿病大鼠系膜基质中度增加,肾小球基底膜增厚。免疫组化观察到系膜和肾小球基底膜中层粘连蛋白、III型和IV型胶原染色增加,而硫酸乙酰肝素蛋白聚糖核心蛋白或硫酸乙酰肝素的肾小球基底膜染色无变化。通过使用特异性抗肾小球基底膜硫酸乙酰肝素单克隆抗体(JM403)的新型抑制ELISA对单个肾小球提取物中的肾小球基底膜硫酸乙酰肝素含量进行定量,结果未改变(中位数(范围)D:314(152 - 941)vs C:262(244 - 467)ng硫酸乙酰肝素/mg肾小球)。然而,作为胶原蛋白含量指标的肾小球4 - 羟脯氨酸量显著增加(D:1665(712 - 2014)vs C:672(515 - 1208)ng/mg肾小球,p < 0.01)。因此,发现硫酸乙酰肝素/4 - 羟脯氨酸比值显著降低(D:0.21(0.14 - 1.16)vs C:0.39(0.30 - 0.47),p < 0.05)。总之,我们证明在链脲佐菌素诱导的糖尿病大鼠中,肾小球高滤过和进行性选择性蛋白尿与肾小球基底膜硫酸乙酰肝素的相对减少有关。从功能上讲,肾小球基底膜内硫酸乙酰肝素相关电荷密度的降低可能解释糖尿病大鼠的选择性蛋白尿。